Systems and methods for treating a mucosal surface

US6706728B2 · kind B2 · utility

Assignee

• 3M INNOVATIVE PROPERTIES COMPANY · US

Inventors

• John C. Hedenstrom · Saint Paul, US
• Michael J. Jozwiakowski · Stillwater, US
• Mark Martinez · Mill Valley, US
• Kenneth R. Phares · Chapel Hill, US
• Kenneth Trofatter · Minnetonka, US

Key dates

• Filing date: Sep 10, 2002
• Grant date: Mar 16, 2004
• Expiry date: Sep 10, 2022

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61M2210/1475
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

A system for treating a condition associated with a mucosal surface, the system comprising an immune response modifier (IRM) compound chosen from imidazoquinoline amines, imidazopyridine amines, 6,7-fused cycloalkylimidazopyridine amines, imidazonaphthyridine amines, oxazoloquinoline amines, thiazoloquinoline amines, 1,2-bridged imidazoquinoline amines, and pharmaceutically acceptable salts thereof and an applicator device for applying the IRM compound to the mucosal surface. This system of IRM compounds and applicator may be used to treat conditions associated with mucosal surfaces such as cervical dysphasia and cervical intraepithelial neoplasia.